IDEXX Laboratories Stock

IDEXX Laboratories EBIT Margin

The EBIT Margin (Operating Margin) of IDEXX Laboratories (IDXX) as of Aug 9, 2026 is 31.60 %. In the previous year, EBIT Margin (Operating Margin) was 28.95 % — a change of 9.16% (higher).

EBIT Margin

31.60 %

YoY

9.16%

Last updated:

EBIT Margin (Operating Margin) of IDEXX Laboratories is 2026 31.60 % . EBIT Margin (Operating Margin) of IDEXX Laboratories was 2025 28.95 % . It decreases by 9.16% higher compared to the previous year.

For IDEXX Laboratories, the operating (EBIT) margin of 31.6% is up versus 29.0% a few years ago.

Access this data via the Eulerpool API

IDEXX Laboratories Stock analysis

What does IDEXX Laboratories do? The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IDEXX Laboratories stock

EBIT Margin (Operating Margin) of IDEXX Laboratories is 31.60 % in 2026.

EBIT Margin (Operating Margin) of IDEXX Laboratories changed from 28.95 % to 31.60 %, representing a 9.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) IDEXX Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s IDEXX Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — IDEXX Laboratories

All Key Metrics — IDEXX Laboratories